Sugi Predict

Sugi Predict / Compounds / SCHEMBL19784879

SCHEMBL19784879

SCHEMBL19784879

c1ccc(-c2ccc3[nH]c4c5ccccc5c5c6ccccc6sc5c4c3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ TNKS O95271 2/20 0.47
▸ TNKS2 Q9H2K2 2/20 0.47
▸ MAP3K9 P80192 3/20 0.43
▸ MAP3K11 Q16584 3/20 0.43
▸ CDK4 P11802 2/20 0.43
▸ CCND1 P24385 2/20 0.43
▸ NTRK1 P04629 1/20 0.39
▸ MAP3K10 Q02779 1/20 0.39
▸ GABRP O00591 1/20 0.39
▸ GABRD O14764 1/20 0.39
▸ GABRA1 P14867 1/20 0.39
▸ GABRB1 P18505 1/20 0.39
▸ GABRG2 P18507 1/20 0.39
▸ GABRB3 P28472 1/20 0.39
▸ GABRA5 P31644 1/20 0.39
▸ GABRA3 P34903 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14951875 1.00 MEN1 (0.51) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL15003805 0.95 MEN1 (0.48) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL18132843 0.92 MEN1 (0.51) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL15126610 0.91 MEN1 (0.47) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL14951206 0.89 MEN1 (0.48) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL14951582 0.89 MEN1 (0.51) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL14951800 0.89 MEN1 (0.48) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL14951565 0.89 MEN1 (0.51) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL19890909 0.89 MEN1 (0.48) MEN1KMT2AMAPTRAB9ATNKS
SCHEMBL14951876 0.87 MEN1 (0.47) MEN1KMT2AMAPTRAB9ATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-27 — — US disclosed
WO-2021230650-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2021-11-18 — — WO disclosed
US-20190229271-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT DUK SAN NEOLUX CO., LTD. (KR) 2019-07-25 — — US disclosed
WO-2018012780-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT 덕산네오룩스 주식회사 2018-01-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF ESR1, GPX1, LEF1 MEN1 652/4885KMT2A 1921/4885MAPT 1456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.